Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

Mycoplasma Detection

Mycoplasmas are potential contaminants in mammalian cell culture manufacturing. To ensure product quality, regulatory agencies recommend that all products produced in cell culture be tested for the presence of Mycoplasma.

MycoSEQ® Mycoplasma Detection System

However, detecting these contaminants is difficult, sometimes impossible, when using traditional microbiological techniques. The current Mycoplasma test is a 28-day culture test. In 2007, the European Pharmacopeia accepted nucleic acid tests, such as real-time PCR, as an alternative method for traditional Mycoplasma detection after validation.

Detect Mycoplasma in Hours, Not Days. It's About Time.

The MycoSEQ® Mycoplasma Detection System integrates real-time PCR assays, instruments, and software with optimized PrepSEQ® sample preparation reagents—delivering results in hours, not days. This enables you to test at multiple points in cell lines, cell banks, and harvest media, increasing your productivity and reducing risk of downstream contamination.

The MycoSEQ® Mycoplasma Detection System’s easy workflow delivers actionable results in less than 4 hours—enabling you to detect contamination as early as possible in process development, equipment, raw materials, and finished product.

  • Detection of more than 90 Mycoplasma species
  • Demonstrated sensitivity to less than 10 copies/reaction
  • Proven specificity
  • Proprietary optimized sample preparation for high DNA recovery
  • Externally validated to demonstrate sensitivity of a PCR-based test for Mycoplasma that is not biased toward the success of PCR
  • Seamless integration from detection to identification using the MicroSEQ® Microbial Identification System.

The MycoSEQ™ Mycoplasma Detection System’s easy workflow delivers actionable results typically in less than 4 hours—enabling you to detect contamination as early as possible in process development, equipment, raw materials, and finished product.

To learn more, click here >>

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- B&W Tek, Inc.
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- CAMO Software AS
- Catalent Pharma Solutions
- CI Precision
- EMD Millipore
- Expo Technologies, LLC.
- GE Analytical Instruments
- HACH LANGE GMBH
- I Holland Limited
- Lonza
- Merck Millipore
- Patheon Inc
- Peter Huber Kältemaschinenbau
- Porvair Sciences Ltd
- Randox Pharma Services
- Rapid Micro Biosystems
- Realia

Add your company here

Whitepapers

Whitepapers available for download:

Increase the Physiological Relevance of HIV Models with RoboSep™
Author: STEMCELL Technologies

A comparison of the attributes of the AccuGENX-ID microbial sequencing methods versus MicroSEQ v2.0
Author: Accugenix

Autoantibody biomarker panels for improved disease diagnosis
Author: Oxford Gene Technology

Utilizing Colony-Forming Cell Assays In Toxicity Testing
Author: STEMCELL Technologies

An Interview with Dr. John Rossi
Author: Integrated DNA Technologies

RNA-Seq Data Comparison with Gene Expression Microarrays
Author: illumina

The importance of being profiled: Improving drug candidate safety and efficacy using cross-target profiling
Author: Merck Millipore

Novo Nordisk and Oxford University team up to develop novel treatments for rheumatoid arthritis

Novo Nordisk and the Kennedy Institute of Rheumatology at Oxford University have announced a new partnership to develop promising new drug candidates and identify novel biomarkers and treatment targets for rheumatoid arthritis and other autoimmune inflammatory diseases...

Read the full story >>

  Arthritic hand

More pharmaceutical & life science news

AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash)
Deal includes lead product lesinurad in Phase III development for gout...

Takeda and AMAG receive a positive CHMP opinion in Europe for Rienso® (ferumoxytol)
For the treatment of iron deficiency anaemia in adult chronic kidney disease patients...

FORXIGA (dapagliflozin) receives positive CHMP opinion in the EU for the treatment of type 2 diabetes
In combination with other glucose-lowering medicinal products including insulin...

GlaxoSmithKline reaches agreement to divest non-core OTC brands for £164 million
Announcement follows divestment of brands in USA, Canada & Europe...

Two phase 3 studies on ultra-long-acting insulin degludec published in The Lancet
Two studies show a significant reduction in the rates of nocturnal hypoglycaemia by 25%, compared to insulin glargine...

A tribute to George Rathmann, Amgen’s founding CEO (1927-2012)
Amgen has announced that George Rathmann, founding CEO of Amgen from 1980 to 1988 and board chairman until 1990, has passed away...

Genzyme demonstrates depth of MS pipeline at AAN with results from Miltiple Sclerosis Phase III trials
Full CARE-MS II results for Alemtuzumab to be unveiled...

Novartis drug Jakavi(TM) recommended by CHMP for EU approval to treat patients with the life-threatening blood cancer myelofibrosis
Upon approval, Jakavi(TM) (INC424, ruxolitinib) will be the first EU approved JAK inhibitor developed to treat patients with myelofibrosis, a rare blood cancer...

FORXIGA® (dapagliflozin) Receives Positive CHMP Opinion in the European Union for the Treatment of Type 2 Diabetes
Bristol-Myers Squibb Company and AstraZeneca announced that the CHMP of the EMA has recommended approval of FORXIGA® (dapagliflozin) tablets...

Abbott receives U.S. FDA clearance to use iFS Advanced Femtosecond Laser technology for arcuate incisions in cataract surgery
Abbott has received U.S. FDA clearance to use its iFS Advanced Femtosecond Laser...

Sanofi and Michael J. Fox Foundation collaborate on potential new treatment for Parkinson’s disease
Fox Foundation to sponsor a clinical trial to study Sanofi compound...

analytica 2012 - Exclusive video interviews

B&W Tek interviewed at analytica 2012
Enrique Lozano Diz, Global Product Manager at B&W Tek, inc speaks to European Pharmaceutical Review at analytica 2012.

Rigaku interviewed at analytica 2012
Elizabeth Yarbrough, Product Marketing Manager at Rigaku speaks to European Pharmaceutical Review at analytica 2012.

Charles River Laboratories at analytica 2012
Yvonne Boss, European In-Vitro Specialist Sales Manager at Charles River Laboratories speaks to European Pharmaceutical Review at analytica 2012.

BaySpec interviewed at analytica 2012
Eric Bergles, Vice President of Sales and Marketing at BaySpec is interviewed by European Pharmaceutical Review at analytica 2012.

Conferences, events & exhibitions:

QA/QC Strategy for Biopharmaceuticals and Biologics
25 - 27 April 2012, Berlin, Germany

Austropharm
26 - 28 April 2012, Vienna, Austria

RNAi & Single Cell Biology-2012 Summit
1 - 2 May 2012, Waltham, USA

INTERPHEX 2012
1 - 3 May 2012 New York, USA

Molecular Diagnostics Europe
10 - 11 May 2012 London, UK

Rational and Safe Prescribing – the way forward
11 May 2012 Dublin, Ireland

Advances in Raman spectroscopy in pharmaceutical analysis
17 May 2012, London, UK

60th ASMS Conference on Mass Spectrometry and Allied Topics
20 - 24 May 2012 Vancouver, Canada

Pharma Outsourcing & Procurement Summit 2012
21 - 22 May 2012 Berlin, Germany

International Conference on Genomics
24 - 26 May 2012, Copenhagen, Denmark

Biobanking
11 - 12 July 2012, London, UK